MOFSL said the three banks stand out due to their strong balance sheets, healthy PCR, and relatively better growth ...

Analysts highlighted momentum in oncology and MedTech, with Wells Fargo calling the second-half growth acceleration “achievable” and Morgan Stanley noting visibility risks from drug pricing and tariff ...